本页面由Tiger Trade Technology Pte. Ltd.提供服务

Jasper Therapeutics

0.4956
-0.0594-10.70%
盘后:0.50010.0045+0.91%19:30 EDT
成交量:42.98万
成交额:22.11万
市值:1,649.09万
市盈率:-0.53
高:0.5400
开:0.5400
低:0.4956
收:0.5550
52周最高:2.69
52周最低:0.3151
股本:3,327.46万
流通股本:2,999.67万
量比:1.30
换手率:1.43%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-3.9545
净资产收益率:-255.05%
总资产收益率:-113.41%
市净率:11.67
市盈率(LYR):-0.13

数据加载中...

2021/10/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/29

重要事件披露

8-K - Current report
2021/09/29

重要事件披露

8-K/A [Amend] - Current report
2021/09/27

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/09/23

重要事件披露

8-K - Current report
2021/09/20

重要事件披露

8-K - Current report
2021/09/20

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/09

重要事件披露

8-K - Current report
2021/09/09

企业合并公告

425 - Prospectuses and communications, business combinations
2021/09/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/08/24

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/06

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/23

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
2021/07/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/07/19

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/07/19

[修订]季度报告

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]